Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of all-trans retinoic acid (ATRA) and anastrozole in pre-operative treatment of operable early breast cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • All-trans retinoic acid (ATRA) (all-trans retinoic acid)
  • Anastrozole (Anastrozole)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Breast Neoplasm Female | Phase 2 | Status: TERMINATED